Mast cell/MDSC a liaison immunosuppressive for tumor microenvironment

OncoImmunology

Volumn 4, Issue 4, 2015, Pages

  Danelli, Luca ^a,b   Frossi, Barbara ^a   Pucillo, Carlo E ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

Author keywords

CD40:CD40L; Colon carcinoma; Immunosuppression; Mast cells; Myeloid derived suppressor cells

Indexed keywords

MACHINE; MAST CELL; SUPPRESSOR CELL; TUMOR MICROENVIRONMENT;

EID: 84954357881     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2014.1001232     Document Type: Article

References (9)

1. Movahedi K, Guilliams M, Van den Bossche J, Van den Bergh R, Gysemans C, Beschin A, De Baetselier P, Van Ginderachter JA. Identification of discrete tumorinduced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008; 111:4233-44; PMID:18272812; http://dx. doi. org/ 10. 1182/blood-2007-07-099226
2. Yang Z, Zhang B, Li D, Lv M, Huang C, Shen G-X, Huang B. Mast cells mobilize myeloid-derived suppressor cells and treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model. PLoS ONE 2010; 5:e8922; PMID:20111717; http://dx. doi. org/ 10. 1371/journal. pone. 0008922
3. Huang B, Lei Z, Zhang G-M, Li D, Song C, Li B, Liu Y, Yuan Y, Unkeless J, Xiong H et al. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 2008; 112:1269-79; PMID:18524989; http://dx. doi. org/10. 1182/blood-2008-03-147033
4. Liu J, Zhang Y, Zhao J, Yang Z, Li D, Katirai F, Huang B. Mast cell: insight into remodeling a tumor microenvironment. Cancer Metastasis Rev 2011; 30:177-84; PMID:21267769; http://dx. doi. org/10. 1007/ s10555-011-9276-1
5. Cheon EC, Khazaie K, Khan MW, Strouch MJ, Krantz SB, Phillips J, Blatner NR, Hix LM, Zhang M, Dennis KL et al. Mast cell 5-lipoxygenase activity promotes intestinal polyposis in APC 468 mice. Cancer Res 2011; 71:1627-36; PMID:21216893; http://dx. doi. org/ 10. 1158/0008-5472. CAN-10-1923
6. Saleem SJ, Martin RK, Morales JK, Sturgill JL, Gibb DR, Graham L, Bear HD, Manjili MH, Ryan JJ, Conrad DH. Cutting edge: mast cells critically augment myeloidderived suppressor cell activity. J Immunol 2012; 189:511-5; PMID:22706087; http://dx. doi. org/ 10. 4049/jimmunol. 1200647
7. Danelli L, Frossi B, Gri G, Mion F, Guarnotta C, Bongiovanni L, Tripodo C, Mariuzzi L, Marzinotto S, Rigoni A et al. Mast cells boost myeloid-derived suppressor cells activity and contribute to the development of tumorfavoring microenvironment. Cancer Immunol Res 2014; 3:85-95; PMID:25351848; http://dx. doi. org/10. 1158/ 2326-6066. CIR-14-0102
8. Ugel S, Peranzoni E, Desantis G, Chioda M, Walter S, Weinschenk T, Ochando JC, Cabrelle A, Mandruzzato S, Bronte V. Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. Cell Rep 2012; 2:1-12; PMID:22959433; http://dx. doi. org/ 10. 1016/j. celrep. 2012. 08. 006
9. Morales JK, Saleem SJ, Martin RK, Saunders BL, Barnstein BO, Faber TW, Pullen NA, Kolawole EM, Brooks KB, Norton SK et al. Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses. J Leukoc Biol 2014; 95:643-50; PMID:24338630; http://dx. doi. org/ 10. 1189/jlb. 0913510